Form 4 for ATRC AtriCure, Inc.
Accepted 2024-01-08 00:00:00 ET · period of report 2024-01-04 · accession 0001323885-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-08 | 2024-01-04 | ATRC | Nachman Shlomo | Dir | A - Grant | $0.00 | +5,322 | 5,322 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | A | A | 5,322 | $0.00 | 5,322 | D | — | — | (F1) The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest 33% annually over three years from the date of grant. |